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Abstract
Aims/hypothesis Obesity during pregnancy increases offspring type 2 diabetes risk. Given that nearly half of women of
child-bearing age in many populations are currently overweight/obese, it is key that we improve our understanding of the
impact of the in utero/early life environment on offspring islet function. Whilst a number of experimental studies have
examined the effect of maternal obesity on offspring islet architecture and/or function, it has not previously been
delineated whether these changes are independent of other confounding risk factors such as obesity, postnatal high-
fat-feeding and ageing. Thus, we aimed to study the impact of exposure to maternal obesity on offspring islets in young,
glucose-tolerant male and female offspring.
Methods Female C57BL/6J mice were fed ad libitum either chow or obesogenic diet prior to and throughout pregnancy and
lactation. Offspring were weaned onto a chow diet and remained on this diet until the end of the study. An IPGTTwas performed
onmale and female offspring at 7 weeks of age. At 8 weeks of age, pancreatic islets were isolated from offspring for measurement
of insulin secretion and content, mitochondrial respiration, ATP content, reactive oxygen species levels, beta and alpha cell mass,
granule and mitochondrial density (by transmission electron microscopy), and mRNA and protein expression by real-time RT-
PCR and Western blotting, respectively.
Results Glucose tolerance was similar irrespective of maternal diet and offspring sex. However, blood glucose was lower
(p < 0.001) and plasma insulin higher (p < 0.05) in female offspring of obese dams 15 min after glucose administration. This
was associated with higher glucose- (p < 0.01) and leucine/glutamine-stimulated (p < 0.05) insulin secretion in these offspring.
Furthermore, there was increased mitochondrial respiration (p < 0.01) and density (p < 0.05) in female offspring of obese dams
compared with same-sex controls. Expression of mitochondrial and nuclear-encoded components of the electron transport chain,
L-type Ca2+ channel subtypes that play a key role in stimulus-secretion coupling [Cacna1d (p < 0.05)], and oestrogen receptor α
(p < 0.05) was also increased in islets from these female offspring of obese dams. Moreover, cleaved caspase-3 expression and
BAX:Bcl-2 were decreased (p < 0.05) reflecting reduced susceptibility to apoptosis. In contrast, in male offspring, glucose and
leucine/glutamine-stimulated insulin secretion was comparable between treatment groups. There was, however, compromised
mitochondrial respiration characterised by decreased ATP synthesis-driven respiration (p < 0.05) and increased uncoupled respi-
ration (p < 0.01), reduced docked insulin granules (p < 0.001), decreased Cacna1c (p < 0.001) and Cacna1d (p < 0.001) and
increased cleaved caspase-3 expression (p < 0.05).
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Conclusions/interpretation Maternal obesity programs sex differences in offspring islet function. Islets of female but not male
offspring appear to be primed to cope with a nutritionally-rich postnatal environment, which may reflect differences in future type
2 diabetes risk.
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Abbreviations
ATP5A ATP synthase F1 subunit α
Avy Agouti viable yellow
BAX Bcl-2-associated X protein
Bcl-2 B cell lymphoma 2
Cav1 L-type voltage-gated Ca
2+ (channel)
DCFDA 2′,7′-dichlorofluorescin diacetate
ERα Oestrogen receptor α
FCCP Carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone
GSIS Glucose-stimulated insulin secretion
HFD High-fat diet
mtDNA Mitochondrial DNA
ROS Reactive oxygen species
STX1A Syntaxin-1A
STXBP1 Syntaxin binding protein 1
TFAM Mitochondrial transcription factor A
UQCRC2 Ubiquinol-cytochrome C reductase core
protein 2
Introduction
Being overweight or obese is a major risk factor for type 2
diabetes. Importantly, overweight/obesity also has health
implications for future generations since obesity during preg-
nancy increases offspring obesity and type 2 diabetes risk.
This was recently highlighted in a study by Lahti-Pulkkinen
et al showing that offspring of obese mothers have a 3.5-fold
increased risk of type 2 diabetes compared with lean mothers
[1]. Abnormalities in beta cell function are critical in delineat-
ing the risk of type 2 diabetes because the inability of beta
cells to adapt and compensate for peripheral insulin resistance
leads to type 2 diabetes pathogenesis [2]. In contrast, sustained
beta cell adaptation is capable of preventing type 2 diabetes,
even in the face of severe insulin resistance [3].
Given that, in many populations, nearly half of women of
child-bearing age are overweight or obese [4], it is important
that we improve our understanding of the impact of the in
utero and early life environment on offspring islet function.
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A number of experimental studies have examined the effect of
maternal obesity on offspring islet architecture and/or function
(reviewed in [5]). Whilst findings of reduced beta cell mass
and impaired glucose-stimulated insulin secretion (GSIS)
suggest increased type 2 diabetes susceptibility, most previous
studies have not delineated whether these changes in islet
structure/function are independent of other confounding risk
factors such as obesity/increased body weight in the offspring
[6–9], postnatal high-fat-feeding [9, 10] and the effects of
ageing [8, 10]. Importantly, research by Zambrano et al in 5-
week-old rat offspring exposed to maternal obesity suggested
that islet function may already be impacted in young life [11].
It is, therefore, key that we identify inherent changes in islet
function, which are programmed by exposure to maternal
obesity per se and are distinct from the response of the islets
to an existing obesogenic, glucose intolerant milieu. This
includes investigating the effects on both male and female
offspring since sex affects glucose homeostasis and type 2
diabetes risk (reviewed in [12]). For example, using a mouse
model of maternal diet-induced obesity, Samuelsson et al
showed increased adiposity in both male and female offspring
at 6 months of age; however, only male offspring developed
type 2 diabetes. This was characterised by higher fasting
glucose, lower fasting insulin and decreased pancreatic insulin
content. In contrast, these variables were unchanged in female
offspring, at the same age [13]. Thus, in the current study,
using this same model we characterised pancreatic islet func-
tion in younger, metabolically healthy male and female
offspring.
Methods
Animal model This research was regulated under the UK
Home Office Animals (Scientific Procedures) Act 1986
following ethical review by the University of Cambridge
Animal Welfare and Ethical Review Board. The model has
been described in detail previously [14]. Briefly, female
C57BL/6J mice were randomised to either ad libitum or a
standard chow RM1 diet (∼7% simple sugars, 3% fat, 50%
polysaccharide, 15% protein [wt/wt], 10.74 kJ/g) or a highly
palatable energy-rich obesogenic diet (∼10% simple sugars,
20% animal lard, 28% polysaccharide, 23% protein [wt/wt],
28.43 kJ/g) and sweetened condensed milk (Nestle) (∼16%
fat, 33% simple sugars, 15% protein, 13.7 kJ/g) fortified with
mineral and vitamin mix (AIN93G), for 6 weeks before
mating for first pregnancy. Diets were purchased from
Special Dietary Services (Witham, UK). Mice were purchased
from Charles River Laboratories (Wilmington, MA, USA).
The first litter was culled post weaning. This first pregnancy
ensured mice were proven breeders. Mice were then re-mated
for a second pregnancy. Dams were maintained on their
respective diets throughout both pregnancies and lactation
periods. Dams fed an obesogenic diet have around 40% body
fat on day one of pregnancy and are hyperinsulinaemic and
have impaired glucose tolerance in late gestation [15]. Litters
were standardised to six pups on postnatal day two. Offspring
from ‘Control’ and ‘Obese’ groups were weaned onto RM1
on postnatal day 21 and remained on this diet until the end of
the study. Mice were housed in ventilated cages, 2–3 mice per
cage with same-sex littermates, and maintained in a humidity-
controlled room with a 12 h light/dark cycle, with free access
to food and water. An IPGTT was performed on 7-week-old
offspring and the offspring were euthanised at 8 weeks of age.
Blood glucose was measured between 07:00 and 08:00 hours
on the day of euthanasia from tail blood sample using a blood
glucose analyser (AlphaTRAK, Abbot Logistics, the
Netherlands). Mice were euthanised by carbon dioxide inha-
lation. Blood was taken by cardiac puncture for serum insulin
analysis. Insulin concentration was determined by ELISA
(Mercodia, Sweden).
IPGTT Following a 4 h fast, glucose (1 g/kg) was injected into
the intraperitoneal cavity. Blood glucose measurements were
made using a blood glucose analyser (AlphaTRAK) at 0, 15,
30, 45, 60, 90 and 120 min. Tail blood was also collected at 0,
15 and 30 min into glass micro-haematocrit capillary tubes
with sodium heparin (Hirschmann-Laborgeräte, Germany)
for plasma insulin analysis. The AUC for glucose was calcu-
lated using the trapezoidal rule.
Pancreatic islet isolation Islets were isolated as described in
[16]. Islets were hand-picked under a stereo microscope and
incubated at 37°C overnight in RPMI-1640 medium supple-
mented with 10% FBS, 100 U/ml penicillin and 100 μg/ml
streptomycin sulphate.
Islet insulin secretion Groups of 20 islets were incubated in
KRB [16] and 2.8 mmol/l glucose for 1 h at 37°C. Next, these
groups of islets were incubated at 37°C for 1 h in KRB
containing 2.8 mmol/l glucose, 16.7 mmol/l glucose or
10 mmol/l leucine/glutamine.
Islet insulin content Islets were washed in PBS mixed with
ethanol/hydrochloric acid and sonicated at 4°C. After centri-
fugation, the supernatant was stored at −20°C until assayed.
Oxygen consumption assay Oxygen consumption was
measured by the XF24 Extracellular Flux Analyzer (Agilent
Technologies, Santa Clara, CA, USA). Groups of 50 islets (in
triplicate) were pre-incubated in KRB with 2 mg/ml BSA and
2.8 mmol/l glucose for 30 min at 37°C. Respiration was
measured in the presence of 16.7 mmol/l glucose, oligomycin,
carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone
(FCCP) and rotenone as previously described [17].
Calculations of basal, glucose-stimulated, ATP-linked and
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proton leak-linked respiration and coupling efficiency were
carried out as previously described [18].
Detection of reactive oxygen species
Reactive oxygen species (ROS) were detected as previously
described [16]. After pre-incubation, islets were loaded with
10 μmol/l 2′,7′-dichlorofluorescin diacetate (DCFDA; Sigma)
and incubated at 37°C for 1 h in KRB containing 2.8 mmol/l
glucose or 16.7 mmol/l glucose. Fluorescence was measured
using a microplate reader with excitation/emission at 495 nm/
529 nm.
Quantification of ATP content This was performed as previ-
ously described [16]. Islets were lysed and the content of ATP
at 2.8 or 16.7 mmol/l glucose was assayed using a luciferase-
based luminescent assay (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s instructions.
Quantification of mRNA expression using quantitative RT-PCR
RNA was extracted (Qiagen, Manchester, UK) and reverse
transcribed into cDNA (Fermentas, Waltham, MA, USA).
Quantitative RT-PCR (qRT-PCR) was performed using
predesigned TaqMan Gene Expression assays or the SYBR
Green system (Thermo Fisher Scientific, Carlsbad, CA,
USA). mRNA expression was determined by theΔΔCt meth-
od and normalised to Rplp0 and Hprt (females) and Actb and
Hprt (males), expression of which was not influenced by
maternal diet. Primer sequences are available in electronic
supplementary material (ESM) Table 1.
Quantification of protein abundance using western blotting
Islets were lysed in RIPA buffer with protease inhibitor cock-
tail (Sigma, Gillingham, UK), subjected to SDS-PAGE and
blotted using antibodies (ESM Table 2). Male and female
samples were run on separate gels. Membranes were sectioned
and some sections stripped (Restore Western Blot Stripping
Buffer, Thermo Fischer Scientific) and re-probed to maximise
the amount of data obtained from each western blot. Image
Lab software version 5.2.1 (Bio-Rad, Hercules, CA, USA)
was used to quantify the density of specific bands. Images of
western blots showing statistically significant differences are
included in ESM Fig. 1. All blots were made available to
Diabetologia at the point of submission.
Mitochondrial DNA content DNAwas extracted (Qiagen) and
quantified (Quant-iT PicoGreen dsDNA Reagent, Thermo
Fisher Scientific). Equal quantities were amplified by qRT-
PCR using primers for nuclear (Rplp0) and mitochondrial
(mt-Nd5) DNA. Mitochondrial (mtDNA) content was deter-
mined as described in [19].
Transmission electron microscopy Samples were prepared as
previously described [16]. Electron micrographs of at least 40
different beta cells from 2–4 mice/sex were taken for each
maternal diet group. Granules (large dense-core vesicles) were
defined as docked when the centre of the granule was located
within 190 nm (a half-length of the mean granule diameter)
from the plasma membrane. The distance between the centre
of the granule and the plasma membrane was calculated using
an in-house software programmed in MatLab 7 (MathWorks,
Natick,MA, USA) [20]. Granule density was estimated accord-
ing to [21] and was normalised to granule diameter assuming
















































































































































Fig. 1 Body weight and glucose tolerance are comparable between
offspring of control and obese dams at 8 weeks of age, irrespective of
sex. (a, b) Glucose excursion curves and AUCs during an IPGTT
performed on 7-week-old male (a) and female (b) offspring of control
and obese dams after a 4 h fast. (c) Plasma insulin concentration at the
15 min time point following glucose administration during an IPGTT in
male and female offspring of control and obese dams. (a, b) Data were
analysed by two-way (repeated measures) ANOVA followed by
Bonferroni’s multiple comparisons test. (c) Data were analysed by two-
way ANOVA followed by a simple main effect analysis when a signifi-
cant interaction was observed. †p < 0.05 and †††p < 0.001 for interaction;
*p < 0.05 and ***p < 0.001 for obese vs control. (a, b) Males, n = 5
mice/group; females, n = 5 mice/group; (c) males, control: n = 5, obese:
n = 4 mice; females, control: n = 5, obese: n = 5 mice. ‘n’ represents the
number of mice from separate litters. All data are mean ± SEM
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spherical geometry [20]. Mitochondrial lesion in beta cells was
determined by Photoshop Elements software (Adobe Systems,
San Jose, CA, USA). The lesion area was outlined and the size
was measured by ImageJ (National Institutes of Health,
Bethesda, MD, USA) and expressed as the area density.
Immunofluorescence Paraffin-embedded pancreas was
exhaustively sectioned (5 μm thickness, 200 μm apart).
Sections were incubated with primary antibody against insulin
[Dako (Agilent Technologies] and glucagon (Bioss Antibodies,
Woburn, MA, USA). The appropriate fluorescent-dye-
conjugated secondary antibodies were used for identifying beta
and alpha cells (Jackson ImmunoResearch, Ely, UK). Digital
images were obtained using Axioscan Z1 Slide Scanner (Zeiss,
Germany) and HALO image analysis platform (Indica Labs,
Albuquerque, NM, USA) was used to calculate immune-
positive and total tissue area. Beta and alpha cell mass was
calculated as described in [22].
Statistical analyses Investigators were not blind to group
assignment and outcome assessment except for analyses of
electron micrographs. Calculations were performed in IBM
SPSS Statistics 23 (Armonk, NY, USA). ‘n’ represents the
number of mice from separate litters. Data are presented as
mean ± SEM of the indicated number of litters. mRNA
expression, protein abundance, mtDNA content and
AUCglucose were analysed using unpaired Student’s t test.
Blood glucose and insulin levels during IPGTT were
measured by two-way (repeated measures) ANOVA followed
by Bonferroni’s multiple comparisons test (note: each sex was
analysed separately). All other data were analysed by two-way
ANOVA. A significant interaction indicated sex differences in
the impact of maternal obesity. In this case, a simple main
effect analysis was performed to isolate the effects of maternal
diet on each sex separately. A probability level of 5%
(p < 0.05) was taken to be significant.
Results
Body weight and glucose tolerance are comparable between
offspring of control and obese dams at 8 weeks of age irre-
spective of sex Body weight, (non-fasted) blood glucose and
serum insulin levels were comparable in 8-week-old offspring
between maternal diet groups (ESM Table 3). Male offspring,
however, were heavier (p < 0.05) and had higher serum insulin
(p < 0.01) (ESM Table 3).
Glucose tolerance in both sexes, as reflected by AUC, was
also similar irrespective of maternal diet (Fig. 1a, b). We

































































































Fig. 2 GSIS is higher in female but not male offspring that were previ-
ously exposed to maternal obesity. (a, b) Beta cell (a) and alpha cell (b)
mass in offspring from control and obese dams at 8 weeks of age. (c)
Insulin secretion stimulated by low glucose (2.8 mmol/l glucose; LG),
high glucose (16.7 mmol/l glucose; HG) and 10 mmol/l leucine/gluta-
mine. (d) Islet insulin content. Experiments were performed on islets
isolated from 8-week-old male and female offspring of control and obese
dams. Data were analysed by two-way ANOVA followed by a simple
main effect analysis when a significant interaction was observed. There
was a significant interaction between maternal diet and offspring sex for
data relating to basal (p < 0.05), glucose-stimulated (p < 0.01) and
leucine/glutamine-stimulated (p < 0.05) insulin secretion, indicating a
sex-specific effect on the outcome measured. *p < 0.05 and **p < 0.01
as shown. (a, b) Males, n = 4 mice/group; females, n = 6 mice/group; (c)
LG: males, control: n = 8, obese: n = 6 mice; females, control: n = 6,
obese: n = 7 mice; HG: males, control: n = 9, obese: n = 7 mice; females,
control: n = 7, obese: n = 8 mice; Leu/Gln: males, control: n = 8, obese:
n = 5 mice; females, control: n = 6, obese: n = 8 mice; (d) males and
females, n = 5 mice/group. ‘n’ represents the number of mice from sepa-
rate litters. All data are mean ± SEM
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and plasma insulin higher (p < 0.05) in female offspring of
obese dams 15 min after glucose administration compared
with controls (Fig. 1b, c).
GSIS is higher in female but not male offspring that were
previously exposed tomaternal obesityThe amount of insulin
secreted by beta cells depends on the mass and function of
these cells. Beta cell mass was comparable between maternal
diet groups (Fig. 2a). However, in line with having higher
serum insulin, male offspring also had increased beta cell
mass (p < 0.05). This was due to higher absolute pancreas
weight (p < 0.05) and consequently greater total pancreatic
tissue area (p < 0.05) with no difference in the relative number
of insulin+ cells (ESM Fig. 2a–c). In contrast, alpha cell mass
was comparable between sexes (Fig. 2b) owing to a lower
number of glucagon+ cells (p < 0.01) in male compared with
female offspring (ESM Fig. 2d).
We found differences in beta cell function between male and
female offspring of obese dams. Basal (p < 0.05), GSIS
(p < 0.01) and amino acid-stimulated (p < 0.05) insulin secretion
were increased only in female offspring of obese dams (Fig. 2c).
Islet insulin content was not different between groups (Fig. 2d).
Sex differences in mitochondrial respiration in offspring of
obese dams To identify cellular components that may be
contributing to enhanced GSIS in female offspring, we
quantified GLUT2 protein abundance, the primary glucose
transporter in rodent islets [23]. This was not altered by
exposure to maternal obesity (Fig. 3a). Subsequent phos-
phorylation of glucose by glucokinase is the key step
controlling glycolytic flux [24]. Glucokinase abundance
was reduced in both male (p < 0.05) and female (p < 0.01)
offspring of obese dams (Fig. 3b). This finding was unex-
pected given that the rate of glycolysis is an important
determinant of GSIS from beta cells.
Mitochondrial metabolism couples glucose metabolism to
insulin secretion. Since leucine/glutamine are mitochondrial
fuels, this suggested that pathways downstream of glucoki-
nase may be activated in these islets. We found sex differences
in mitochondrial function in offspring of obese dams. Whilst
exposure to maternal obesity resulted in higher basal respira-
tion irrespective of offspring sex (p < 0.01) (Fig. 3c–e),
glucose-stimulated (relative to basal) respiration was reduced
inmales (p < 0.05) but increased in female (p < 0.01) offspring
of obese dams (Fig. 3c, d, f).
Respiration rate is mostly composed of ATP-linked and

































































































































































































































































































































Fig. 3 Sex differences in mitochondrial respiration in offspring of obese
dams. (a, b) Western blot analysis of GLUT2 (a) and glucokinase (GK)
(b); images of corresponding western blots are in ESM Fig. 1a, b,
respectively. (c, d) Changes in islet oxygen consumption rate in male
(c) and female (d) offspring of control and obese dams following
treatment with 16.7 mmol/l glucose, 4 μg/ml oligomycin, 4 μmol/l
FCCP and 5 μmol/l rotenone. (e–i) Basal (2.8 mmol/l glucose)
respiration (e), glucose-simulated respiration (16.7 mmol/l glucose) (f),
ATP-linked respiration (g), coupling efficiency (h) and proton leak-linked
respiration (i). Experiments were performed on islets isolated from 8-
week-old male and female offspring of control and obese dams. (a, b)
Data were analysed by unpaired Student’s t test (control vs obese); (e–i)
data were analysed by two-way ANOVA followed by a simple main
effect analysis and a Sidak’s multiple comparisons test when a
significant interaction was observed. †p < 0.05 and ††p < 0.01 for
interaction; *p < 0.05 and **p < 0.01 as shown. (a, b) Males and
females, control: n = 7, obese: n = 5 mice; (c–i) males, n = 3
mice/group; females, n = 4 mice/group. ‘n’ represents the number of
mice from separate litters. All data are mean ± SEM
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stimulated respiration, ATP-linked respiration was reduced in
male offspring of obese dams (p < 0.05) (Fig. 3g). Moreover,
coupling efficiency, which estimates the fraction of respiration
used to drive ATP synthesis was also reduced in these islets
(p < 0.01) (Fig. 3h). In contrast, ATP-linked respiration was
increased in female offspring of obese dams (p < 0.01) (Fig.
3g). Finally, we also found that proton leak-linked respiration
was higher in islets from maternal obesity-exposed offspring
(p < 0.05) (Fig. 3i). This appears to be driven by a relatively
large difference between female offspring groups due to lower
proton leak-linked respiration in the control group.
Only female offspring of obese dams have increased expres-
sion of mitochondrial and nuclear-encoded components of
the electron transport chain Mitochondrial respiration/
function is dependent on mtDNA, genes of the respiratory
chain complexes that it encodes and its nuclear-encoded
constituents. mRNA expression of some mitochondrial-
encoded components of the respiratory complexes was signif-
icantly increased in maternal obesity-exposed female
offspring (Fig. 4a). This was not due to higher levels of mito-
chondrial transcription factor A (TFAM) (Fig. 4b) but may be
partly due to increased number of mitochondria as evidenced
by higher mitochondrial area density (p < 0.05) (Fig. 4c).
There was, however, no statistical difference in mtDNA
content (p < 0.06; Fig. 4d). In addition to mitochondrial genes,
mRNA expression of Sdha (Complex II) (p < 0.05) (Fig. 4a)































































































































































Fig. 4 Among female offspring, only the offspring of obese dams have
increased expression of mitochondrial and nuclear-encoded components
of the electron transport chain. (a) qRT-PCR analysis of mRNA expres-
sion of mitochondrial (mt-Nd5, mt-Cytb, mt-Co1, mt-Atp8) and nuclear
(Sdha) encoded components of the electron transport chain. (b) Western
blot analysis of mitochondrial transcription factor A (TFAM); image of
corresponding western blot is in ESM Fig. 1c. (c) Mitochondrial area
density. (d) Mitochondrial DNA content. (e) Western blot analysis of
mitochondrial (MT-CO1) and nuclear (NDUFB8, SDHB, UQCRC2
and ATP5A) encoded components of the electron transport chain; images
of corresponding western blots are in ESM Fig. 1d. Experiments relating
to (a, b, d, e) were performed on islets from female offspring and (c) was
performed on islets isolated from 8-week-old male and female offspring
of control and obese dams. (a, b, d, e) Data were analysed independently
by unpaired Student’s t test (control vs obese). (c) Data were analysed by
two-way ANOVA followed by a simple main effect analysis when a
significant interaction was observed. †p < 0.05 for interaction; *p < 0.05,
**p < 0.01 and ***p < 0.001 as shown. (a) mt-Nd5, control: n = 11,
obese: n = 11; Sdha, control: n = 9, obese: n = 8; mt-Cytb, control: n =
12, obese: n = 11; mt-Co1, control: n = 11, obese: n = 10; Atp8, control:
n = 12, obese: n = 10mice; (b) n = 5mice/group; (d) n = 8mice/group; (e)
NDUFB8, control: n = 6, obese: n = 4; SDHB, UQCRC2, MT-CO1 and
ATP5A, control: n = 7, obese: n = 5 mice; ‘n’ represents the number of
mice from separate litters; in (c) the data points shown correspond to the
number of beta cells from: males, control: n = 2, obese: n = 4 mice;
females, control: n = 2, obese: n = 3 mice. All data are mean ± SEM.
For (a, b, d, e) the equivalent graphs for male offspring are in ESM






































































































































Fig. 5 ROS is increased in islets from both male and female offspring of
obese dams but expression of antioxidant enzyme is increased only in
female islets. (a, b) ROS levels measured by DCFDA fluorescence inten-
sity following incubation with 2.8 mmol/l glucose (a) or 16.7 mmol/l
glucose (b). (c, d) qRT-PCR analysis of Cat and Sod2mRNA expression
in male (c) and female (d) offspring. Experiments were performed on
islets isolated from 8-week-old male and female offspring of control
and obese dams. (a, b) Data were analysed by two-way ANOVA follow-
ed by a simple main effect analysis when a significant interaction was
observed. (c, d) Data were analysed independently by unpaired Student’s
t test (control vs obese). *p < 0.05 and **p < 0.01 as shown. (a, b) Males,
control: n = 7, obese: n = 5 mice; females, control: n = 8, obese: n = 4
mice; (c, d)Cat: males, control: n = 7, obese: n = 8mice; females, control:
n = 7, obese: n = 7 mice; Sod2: males, control: n = 8, obese: n = 6 mice;
females, control: n = 9, obese: n = 9 mice. ‘n’ represents the number of
mice from separate litters. All data are mean ± SEM
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Complex II) (p < 0.01), ubiquinol-cytochrome C reductase
core protein 2 (UQCRC2; Complex III) (p < 0.05) and
ATP5A (Complex V) (p < 0.01), which are nuclear-encoded,
were also increased (Fig. 4e).
Our results suggest that higher mitochondrial respiration in
female offspring of obese dams could be due to having more
mitochondria and higher levels of respiratory complex
proteins. The converse is not the case for male offspring
(ESM Fig. 3a–d and Fig. 4c).
Increased ROS in islets from both male and female offspring
of obese dams but increased expression of antioxidant
enzyme only in female isletsMitochondria are a major source
of intracellular ROS [26]. Basal ROS levels were comparable
between offspring groups (Fig. 5a). In response to glucose
stimulation, ROS levels were higher in islets of maternal
obesity-exposed offspring (p < 0.05) (Fig. 5b). Thus, in the
case of male offspring of obese dams, ROS levels are elevated
even with reduced mitochondrial respiration. Furthermore,
female but not male offspring of obese dams displayed
increased Sod2 (p < 0.01) (but not Cat) mRNA expression
(Fig. 5c, d) suggesting that islets from these male offspring
may be more vulnerable to oxidative stress.
Reduction in L-type Ca2+ channels and docked insulin gran-
ules in beta cells from male offspring that were previously
exposed to maternal obesity Activation of L-type voltage-
gated Ca2+ (CaV1) channels are essential for insulin secretion
[27, 28]. Exposure to maternal obesity resulted in sex-specific
differences in expression of the two subtypes of CaV1 chan-
nels: Cacna1c and Cacna1d (which encode CaV1.2 and
CaV1.3, respectively). Cacna1d expression was increased in
females (p < 0.05) but both Cacna1c and Cacna1d expression
was decreased in male (p < 0.001) offspring of obese dams
(Fig. 6a, b). Downregulation of these genes has been observed
in both human and rodent type 2 diabetic islets [29–31].
Docking of secretory vesicles is required for insulin exocy-
tosis [20, 32]. Insulin granule density was reduced in beta cells
of maternal obesity-exposed offspring of both sexes (p < 0.01)
(Fig. 6c). We found, however, that the area of docked granules
was decreased only in male offspring of obese dams
(p < 0.001) (Fig. 6d). Furthermore, the number of granules
in the first fraction beneath the plasma membrane (0.19 μm
from the plasma membrane) was reduced (p < 0.01) whilst
those in the second fraction (0.38 μm from the plasma
membrane) were increased (p < 0.001) in these mice (Fig.
6e). These results suggest that granules may be stacking in
the second fraction (which is considered to be the reserve
pool) owing to dysfunctional docking in beta cells of these
mice. Expression of syntaxin-1A (STX1A) and syntaxin bind-
ing protein 1 (STXBP1) proteins, which are required for
docking [33] was unchanged in both male and female
offspring (Fig. 6g, h).
Islets from female offspring of obese dams may be protected
from dysfunction by increased oestrogen receptor α and
reduced susceptibility to apoptosis 17β-oestradiol has been
shown to protect females from beta cell death and
hyperglycaemia via oestrogen receptor α (ERα) [34–36]. In
our model, ERα protein abundance was higher in female
offspring of obese dams (p < 0.05) (Fig. 7a). Furthermore,
expression of cleaved (activated) caspase-3, the key mediator
of the apoptotic cascade in mammalian cells [37] was
decreased (p < 0.05) in these offspring (Fig. 7b). In contrast,
cleaved caspase-3 abundance and Casp3 mRNA expression
were increased in male offspring of obese dams (p < 0.05)
(Fig. 7b, c).
The mitochondrial phenotype in this study prompted us to
investigate whether the mitochondrial intrinsic apoptosis path-
way could be contributing to changes in caspase-3 activity.
mRNA expression of Casp9, the initiator caspase involved
in this pathway, was higher in male offspring of obese dams
(p < 0.05) (Fig. 7d). Furthermore, the ratio of pro-apoptotic
BAX to anti-apoptotic Bcl-2, which can profoundly influence
the ability of a cell to respond to an apoptotic signal [38], was
lower in female offspring of obese dams (p < 0.05) (Fig. 7e).
This suggests a downregulation of the mitochondrial apopto-
sis pathway in these offspring. There were no differences in
Fig. 6 Reduction in L-type Ca2+ channels and docked insulin granules in
beta cells from male offspring that were previously exposed to maternal
obesity. (a, b) qRT-PCR analysis of Cacna1c and Cacna1d mRNA
expression in male (a) and female (b) offspring. (c–f) Transmission
electron microscopy analysis of insulin granule density (c) and docked
granules estimated by the surface density (d). Relative distribution of
granules at distance fractions from the plasma membrane (e). Granules
were defined as docked if their distance from the plasma membrane was
0.19 μm, i.e. half the size of the mean granule diameter. Representative
transmission electron microscopy micrographs of beta cells from male
and female offspring of control and obese dams (f). The right-hand image
is a magnification of the inset in the left-hand image; scale bars, 2 μm for
the left-hand image in each set and 500 nm for the magnification. (g, h)
Western blot analysis of STX1A (g) and STXBP1 (h); images of
corresponding western blots are in ESM Fig. 1e, f, respectively.
Experiments were performed on islets isolated from 8-week-old male
and female offspring of control and obese dams. (c–e) Data were
analysed by two-way ANOVA followed by a simple main effect
analysis when a significant interaction was observed. Analyses based
on individual animals (n = 2–4 mice/group) showed no statistically
significant difference within the groups; thus, cell-based analyses (n =
40–59 cells/group) were performed. (a, b, g, h) Data were analysed
independently by unpaired Student’s t test (control vs obese). ††p < 0.01
for interaction; *p < 0.05, **p < 0.01 and ***p < 0.001 as shown. In (b),
p = 0.05 forCacna1cmRNA expression in female offspring of control vs
obese dams. (a, b) Cacna1c: males, control: n = 6, obese: n = 8 mice;
females, control: n = 8, obese: n = 6 mice; Cacna1d: males, control: n =
6, obese: n = 8 mice; females, control: n = 7, obese: n = 6 mice; (g) males,
control: n = 5, obese: n = 4 mice; females, control: n = 6, obese: n = 5
mice; (h) males, control: n = 6, obese: n = 4 mice; females, control: n =
6, obese: n = 6 mice; ‘n’ represents the number of mice from separate
litters; in (c, d) the data points shown correspond to the number of beta
cells from: males, control: n = 2, obese: n = 4 mice; females, control: n =
2, obese: n = 3 mice. All data are mean ± SEM
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protein levels of BAX and Bcl-2 between offspring of mater-
nal diet groups (ESM Fig. 4a, b).
Discussion
Whilst there are known genetic risk factors that may be trans-
ferred from mother to child, which explain future obesity and
type 2 diabetes risk, the picture is far from complete. Studies
in humans that have controlled for shared genetics found that
individuals exposed to maternal obesity/gestational diabetes
had a greater diabetes and obesity risk compared with unex-
posed individuals [39–41]. Furthermore, a recent record-
linkage study involving 118,201 mothers and their offspring
found that being overweight or obese in mothers is associated
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Given that in humans a mother’s genes and environment
co-exist, rodent models of obesogenic diet-induced obesity
across pregnancy and lactation, which resemble the human
situation, have been key in our understanding of the non-
genetic transfer of metabolic disease risk from mother to
offspring. A number of studies have suggested that increased
type 2 diabetes susceptibility in developmentally programmed
offspring is due to altered pancreatic islet architecture and/or
function (reviewed in [5]). The strength of this study is that it
is the first to outline the sex-specific changes in islet function
in offspring born to obese dams that are present before and are,
therefore, independent of offspring obesity, glucose intoler-
ance and ageing. This is important as it allows us to elucidate
islet processes that are most vulnerable to dysfunction thus
leading to higher type 2 diabetes risk in offspring exposed to
maternal obesity.
A limitation of this study is that we did not measure adipos-
ity in male and female offspring at 8 weeks of age. Previous
studies in this model have shown, however, that fat mass is
comparable in 8-week-old offspring from control and obese
dams irrespective of sex [42, 43].
It has been shown previously, using the same model of
maternal diet-induced obesity, that whilst both male and female
offspring develop obesity and insulin resistance with age,
female offspring of obese dams are less susceptible to type 2
diabetes at 6 months of age [13]. Our findings suggest that islets
from female offspring are primed to handle a nutritionally-rich
postnatal environment by upregulating mitochondrial respira-
tion and CaV1 expression leading to higher GSIS. Therefore,
despite being ‘overworked’ from a young age, these islets
appear to have protective mechanisms in place to cope with
the demands of increasing adiposity and insulin resistance
(Fig. 8). For example, reduced glucokinase expression could
act to temper glycolysis in the face of increased mitochondrial
metabolism so as to maintain a healthy redox balance [44].
Increased proton leak-linked respiration may also not necessar-
ily be damaging (especially since coupling efficiency is main-
tained). Mitochondrial superoxide production is steeply depen-
dent on the protonmotive force across the inner mitochondrial
membrane. Thus, increased proton leak may act to minimise
oxidative damage by moderating the protonmotive force and,
therefore, ROS production [45]. Furthermore, increased ERα
levels could also have a positive influence on these islets by
preservingmitochondrial function [46] and protecting beta cells
from apoptosis [34–36]. Indeed, oestrogen-based replacement
therapies have been shown to reduce type 2 diabetes incidence
in post-menopausal women [47, 48]. As part of future studies, it
will be important to determine if serum oestradiol levels are also
different between offspring groups. Moreover, it will be key to
elucidate islet function and type 2 diabetes risk in post-meno-
pausal, maternal obesity-exposed mice.
In line with the observation that women have lowered risk
for type 2 diabetes [49], females appear to be protected from
beta cell death in most rodent models of type 2 diabetes [12,
50]. In the case of exposure to maternal diet-induced obesity/
high-fat-feeding and future type 2 diabetes risk in the
offspring, Yokomizo and colleagues showed that islets from
female offspring were better able to compensate and adapt to a
high-fat diet (HFD) in postnatal life compared with male
offspring [9]. Interestingly, in a study of maternal obesity
using the agouti viable yellow (Avy) mouse, (aged) female
offspring developed glucose intolerance and had reduced
GSIS following postnatal HFD compared with males [10].
This is in contrast to findings by Li and colleagues, which
showed that the latent predisposition to metabolic disease in
offspring of Avy dams, was more prominent in males who
developed glucose intolerance and insulin resistance after only































































































































































Fig. 7 Islets from female offspring of obese dams may be protected from
dysfunction by increased ERα and reduced susceptibility to apoptosis. (a,
b) Western blot analysis of ERα (a) and cleaved caspase-3 (b) protein
abundance; images of corresponding western blots are in ESM Fig. 1g, h,
respectively. (c, d) qRT-PCR analysis ofCasp3 (c) andCasp9 (d) mRNA
expression in male and female offspring. (e) Western blot analysis of
BAX:Bcl-2 ratio; images of corresponding western blots are in ESM
Fig. 1i (BAX) and ESM Fig. 1j (Bcl-2). Experiments were performed
on islets isolated from 8-week-old male and female offspring of control
and obese dams. Males and females were analysed independently by
unpaired Student’s t test (control vs obese). *p < 0.05, as shown. (a)
Males, control: n = 7, obese: n = 5 mice; females, control: n = 6, obese:
n = 5 mice; (b) males, n = 5 mice/group; females, control: n = 6, obese:
n = 4 mice; (c, d) males, control: n = 5, obese: n = 6 mice; females,
control: n = 9, obese: n = 7 mice; (e) BAX: males, n = 5 mice/group;
females, control: n = 5, obese: n = 4 mice; Bcl-2: males and females,
control: n = 5, obese: n = 4 mice. ‘n’ represents the number of mice from
separate litters. All data are mean ± SEM
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most models of maternal diet-induced obesity, Avy mice are
normoglycaemic during pregnancy.
In humans, men are diagnosed with type 2 diabetes at a
younger age and at lower levels of adiposity than women [49].
The male sex is also acknowledged as a diabetes risk factor
[52]. In this study, islets from maternal obesity-exposed male
offspring appear not to fare as well as females (Fig. 8). This
manifests as suboptimal mitochondrial respiration. Unlike in
females, these changes could not be attributed to changes in
mtDNA content or the expression of genes encoding compo-
nents of the electron transport chain. The mitochondria in
islets of male offspring seem particularly vulnerable to insults
in utero/early life; male offspring that experienced intrauterine
growth restriction followed by postnatal catch-up growth also
showed impaired mitochondrial function and increased ROS
production prior to the onset of diabetes [53]. There may,
therefore, be common responses operating as a result of
suboptimal nutrition in utero. There is a 50% reduction in
the expression of Cacna1c and Cacna1d, which is key for
GSIS, along with impairment of docking of insulin granules
in male offspring of obese dams. The latter could be due to
reduced ATP levels [54] owing to reduced ATP-linked respi-
ration in these islets. Whilst not yet detrimental to GSIS at this
age, these changes could mean that their islets are more
vulnerable to metabolic insult/stress. This may partly explain
why islets from maternal obesity-exposed male offspring that
were subsequently exposed to a ‘second hit’ of high-fat feed-
ing in postnatal life are more vulnerable to dysfunction
compared with females [9]. Furthermore, our results highlight
the role of pancreatic islets in conferring increased type 2
diabetes risk in male offspring exposed to maternal obesity.
Type 2 diabetes is associated with islet dysfunction and
altered endocrine cell mass [55]. Whilst we found no differ-
ence in offspring beta/alpha cell mass, previous studies
showed that maternal HFD impacted on offspring endocrine
cell mass/number in neonatal and/or adult life (reviewed in
[5]). Importantly, these studies also provided evidence for
the dynamic nature of beta cell mass in these offspring and
its ability to adapt to altered metabolic demand. Neonates
exposed to maternal HFD throughout gestation have reduced
beta cell number and volume at birth [56] but this difference
disappears in adolescence [57]. Furthermore, exposure to
maternal obesity led to reduced beta cell mass in 36-day-old
offspring but this was higher at 110 days [11]. Thus, it is likely
that differences between studies are due to differences in the
age and metabolic status of the offspring at the time of inves-
tigation. Finally, it is also important to consider changes in
beta cell mass in the context of its functional state since beta
cells can occur under different phenotypes that vary with age
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Fig. 8 Exposure to maternal obesity programs sex differences in pancreatic islets of the offspring in mice
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Looking to the future, it is important to improve our
understanding of the possible maternal factors, e.g.
hyperinsulinaemia, hyperglycaemia and hyperlipidaemia,
underlying the programming of metabolic adversity across
the life course of the offspring. Furthermore, it is also key
that we identify the critical developmental period(s) during
which suboptimal maternal nutrition programs altered islet
function in the offspring.
In summary, the current findings suggest that sex differ-
ences in type 2 diabetes susceptibility in offspring as a conse-
quence of exposure to maternal obesity could, at least in part,
be driven by differences in islet function. Females, in response
to nutritional cues from the mother signalling a nutrient-rich
environment, prime islet development to thrive in this envi-
ronment postnatally. In contrast, males may respond to these
cues in a manner that minimises the risk of neonatal
hypoglycaemia and maximises neonatal survival. However,
this becomes maladaptive in later life following the onset of
obesity and insulin resistance in these male offspring.
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